New Agents for AMD Preserve Vision, Dramatically Reduce Treatment Burden

(MedPage Today) -- MONTREAL--An investigational bispecific antibody for retinal disease achieved faster and numerically greater short-term improvements in visual acuity and retinal anatomy versus faricimab (Vabysmo), a randomized, proof-of...